Treatment of idiopathic hypersomnia with modafinil in an individual at clinical high risk for psychosis: A case report
This case demonstrates modafinil's efficacy and safety in treating IH in individuals with CHR-P. However, whether modafinil use increases the risk of transition to psychosis remains unclear. Further research is required on modafinil as a treatment for hypersomnia in individuals with CHR-P.
Authors
- Yutaro Sato (ORCID: https://orcid.org/0000-0002-0050-8942)
- Hiroaki Tomita (ORCID: https://orcid.org/0000-0003-2628-880X)
- Atsushi Sakuma (ORCID: https://orcid.org/0000-0002-9290-5311)
Institutions
- Tohoku University (JP)
- Tohoku University Hospital (JP)
- Sendai Medical Center (JP)
- National Hospital Organization (JP)
Publication Details
- Journal
- Psychiatry and Clinical Neurosciences Reports
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1002/pcn5.70115
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science